Significantly increased IL-33 levels have been detected in RA patients’ serum and synovial fluid, and IL-33 levels have been shown to positively correlate with disease severity, rheumatoid factor, and anticitrullinated protein antibodies (37–39). The gene discussed is IL33; the disease is rheumatoid arthritis.